Inhwan Hwang

Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis

JiHoon Kang, Inhwan Hwang, Changhoon Yoo et al. · Investigational New Drugs · 2018 · 147 citations

Medicine, Oncology, Pharmacology +13

Hyperprogressive Disease in Patients With Urothelial Carcinoma or Renal Cell Carcinoma Treated With PD-1/PD-L1 Inhibitors

Inhwan Hwang, Inkeun Park, Shinkyo Yoon et al. · Clinical Genitourinary Cancer · 2019 · 36 citations

Medicine, Oncology, Urology +17

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma

Changhoon Yoo, Inhwan Hwang, Tae Jun Song et al. · Therapeutic Advances in Medical Oncology · 2020 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study

Eun‐Hee Nah, Seon Cho, Hyeran Park et al. · BMJ Open · 2021 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores

Inhwan Hwang, JiHoon Kang, Hei Nga Natalie Ip et al. · Investigational New Drugs · 2018 · 20 citations

Medicine, Oncology, Pharmacology +14